NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- The International Society of Peritoneal Dialysis Celebrates 40 Years Posted 10-15-2024
- Michael Aragon, MD Article in DocWireNews on Switching from PD to Home HD Posted 10-15-2024
- PD Excellence Academy Offers Three New Courses and Up to 11 CE Credits Posted 09-12-2024
- New Fresenius Versi®HD Now has GuideMe Software Posted 09-12-2024